What were Celanese's Q2 adjusted EPS and how did it compare to analyst expectations?

Celanese's Q2 adjusted earnings per share (EPS) came to $2.45, which was up 188% sequentially and 71% year over year, and ahead of the analysts’ consensus estimate of $2.22 as compiled by S&P Capital IQ.

Which segment drove the strongest margin expansion in Q2, and what were its key performance metrics?

The acetyl chain segment drove the strongest margin expansion in Q2, reporting sales of $1.33 billion (up 28% sequentially), operating EBITDA of $385 million (up 99% sequentially), and an operating EBITDA margin of 29.0% — an increase of 1,030 basis points sequentially.

Celanese Q2 beats estimates amid soaring acetyl pricing

Aug 5, 2026

Celanese Corp beat Q2 earnings estimates as acetyl pricing surged 22%, boosting the acetyl chain segment significantly. The company maintained full-year guidance despite expecting moderated opportunities and higher raw material costs in Q3.

chemweek

Celanese Q2 Beats Estimates Amid Soaring Acetyl Pricing

chemweek

2026-06-05

Celanese to Close Ulsan Compounding Facility

2026-08-05

Celanese Q2 beats estimates amid soaring acetyl pricing

2026-08-19

Celanese signs partnership on plastics for humanoid robots

2026-09-01

Celanese sells additional 19% stake in Nutrinova to Mitsui & Co. for $152M

Celanese Q2 beats estimates amid soaring acetyl pricing

FAQ